
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
What are the health benefits of whole milk for kids? - 2
SpaceX launches Starlink satellites from California on 160th Falcon 9 flight of the year (video) - 3
Three arrested in Paris after attempted bomb attack outside Bank of America - 4
The Force of Positive Reasoning: Day to day Attestations - 5
Surprising links between autism, Alzheimer’s could change how we treat both
Smartwatches: Remain Associated and Dynamic
Former biotech CEO sued over COVID vaccine alleged insider trading
Teen drug use remains low, but survey finds small rise in heroin and cocaine use
Why Cannes Is the Ultimate New Year’s Eve Destination in the South of France’s Off-Season
Computerized Moderation: Tracking down Equilibrium in the Advanced Age
Google's proposed data center in orbit will face issues with space debris in an already crowded orbit
Step by step instructions to Keep up with the Life span of Your Kona SUV's Battery Duration
4 African Vacationer Locations
Farewell, comet 3I/ATLAS! Interstellar visitor heads for the outer solar system after its closest approach to Earth













